SciSparc to Acquire AutoMax
April 11, 2024
Acasti to Proceed with Phase 3 Clinical Safety Study for GTX-104 Following FDA Feedback, and Upon Approval of the Full Study Protocol to be Submitted to the IND
April 4, 2023
Related Post
-
-
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
April 11, 2024
-
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
April 11, 2024
-
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
April 11, 2024